Overview
Dr. Maldonado specializes in pediatric retinal diseases, pediatric and adult ophthalmic genetics, and inherited retinal diseases. He completed a fellowship in pediatric retinal imaging at Duke Ophthalmology. He also completed ophthalmic genetics and electrophysiology and medical retina fellowships at the National Institutes of Health (NIH-NEI).
Prior to joining Duke, he was the Director and Founder of the Ophthalmic Genetics and Electrophysiology Service at the University of Kentucky Medical Center.
Dr. Maldonado provides pediatric medical retina services in addition to pediatric and adult inherited retinal disease care.
Prior to joining Duke, he was the Director and Founder of the Ophthalmic Genetics and Electrophysiology Service at the University of Kentucky Medical Center.
Dr. Maldonado provides pediatric medical retina services in addition to pediatric and adult inherited retinal disease care.
Current Appointments & Affiliations
Associate Professor of Ophthalmology
·
2024 - Present
Ophthalmology, Vitreoretinal Diseases & Surgery,
Ophthalmology
Recent Publications
Characterizing the Genetic Basis for Inherited Retinal Disease: Lessons Learned From the Foundation Fighting Blindness Clinical Consortium's Gene Poll.
Journal Article Invest Ophthalmol Vis Sci · February 3, 2025 PURPOSE: The Foundation Fighting Blindness (FFB) Consortium is a collaboration of 41 international clinical centers that manage patients affected with inherited retinal diseases (IRDs). The annual Consortium gene poll was initiated in 2020 to capture the g ... Full text Link to item CiteGalloway-Mowat syndrome with retinal involvement associated with a novel WDR73 variant: case report and review of the literature.
Journal Article Ophthalmic Genet · February 2025 INTRODUCTION: Galloway-Mowat syndrome (GAMOS) is a rare autosomal recessive disorder classically characterized by central nervous system and renal abnormalities. Optic atrophy has been reported as a common ophthalmic feature, and other characteristics, inc ... Full text Link to item CiteANATOMICAL AND FUNCTIONAL OUTCOMES OF BEVACIZUMAB TREATMENT IN PEDIATRIC AUTOSOMAL RECESSIVE BESTROPHINOPATHY.
Journal Article Retin Cases Brief Rep · May 1, 2024 PURPOSE: The purpose of this study was to report functional and anatomical outcomes of anti-VEGF treatment in eyes with autosomal recessive bestrophinopathy (ARB) presenting in the first decade of life. METHODS: The study included case series of four eyes ... Full text Link to item CiteRecent Grants
A Phase 1/2, First-in-Human, Open-label, Assessor-Masked, Randomized, Controlled, Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects with Stargardt Disease (ST
Clinical TrialPrincipal Investigator · Awarded by SpliceBio, SL · 2025 - 2030A Randomized, Double-Masked, Controlled, Parallel-Group, Multicenter, Phase 2/3 Clinical Trial Investigating the Efficacy and Safety of ADX-2191 in Adults with Retinitis Pigmentosa
Clinical TrialPrincipal Investigator · Awarded by Aldeyra Therapeutics · 2024 - 2029A Phase 2/3, Randomized, Controlled, Masked, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Two Doses of AGTC-501, a Recombinant Adeno-associated Virus Vector Expressing RPGR (rAAV2tYF-GRK1-RPGR), Compared to an Untreated
Clinical TrialPrincipal Investigator · Awarded by Beacon Therapeutics, Inc. · 2024 - 2029View All Grants